247 related articles for article (PubMed ID: 2206036)
1. Expanded clinical evaluation of lovastatin (EXCEL) study: design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesterolemia.
Bradford RH; Shear CL; Chremos AN; Dujovne C; Franklin FA; Hesney M; Higgins J; Langendörfer A; Pool JL; Schnaper H
Am J Cardiol; 1990 Sep; 66(8):44B-55B. PubMed ID: 2206036
[TBL] [Abstract][Full Text] [Related]
2. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia.
Bradford RH; Shear CL; Chremos AN; Dujovne C; Downton M; Franklin FA; Gould AL; Hesney M; Higgins J; Hurley DP
Arch Intern Med; 1991 Jan; 151(1):43-9. PubMed ID: 1985608
[TBL] [Abstract][Full Text] [Related]
3. Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia.
Bradford RH; Shear CL; Chremos AN; Franklin FA; Nash DT; Hurley DP; Dujovne CA; Pool JL; Schnaper H; Hesney M
Am J Med; 1991 Jul; 91(1B):18S-24S. PubMed ID: 1867232
[TBL] [Abstract][Full Text] [Related]
4. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
[TBL] [Abstract][Full Text] [Related]
5. A comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia.
D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC
Am J Cardiol; 1992 Jan; 69(1):28-34. PubMed ID: 1729864
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of lovastatin in 3390 women with moderate hypercholesterolemia.
Bradford RH; Downton M; Chremos AN; Langendörfer A; Stinnett S; Nash DT; Mantell G; Shear CL
Ann Intern Med; 1993 Jun; 118(11):850-5. PubMed ID: 8480959
[TBL] [Abstract][Full Text] [Related]
7. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. Effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteins.
Shear CL; Franklin FA; Stinnett S; Hurley DP; Bradford RH; Chremos AN; Nash DT; Langendorfer A
Circulation; 1992 Apr; 85(4):1293-303. PubMed ID: 1555273
[TBL] [Abstract][Full Text] [Related]
8. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: two-year efficacy and safety follow-up.
Bradford RH; Shear CL; Chremos AN; Dujovne CA; Franklin FA; Grillo RB; Higgins J; Langendorfer A; Nash DT; Pool JL
Am J Cardiol; 1994 Oct; 74(7):667-73. PubMed ID: 7942524
[TBL] [Abstract][Full Text] [Related]
9. A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d.
Davidson MH; Palmisano J; Wilson H; Liss C; Dicklin MR
Clin Ther; 2003 Nov; 25(11):2738-53. PubMed ID: 14693301
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of lovastatin in 459 African-Americans with hypercholesterolemia.
Prisant LM; Downton M; Watkins LO; Schnaper H; Bradford RH; Chremos AN; Langendörfer A
Am J Cardiol; 1996 Aug; 78(4):420-4. PubMed ID: 8752186
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia.
Hunninghake DB; Stein EA; Dujovne CA; Harris WS; Feldman EB; Miller VT; Tobert JA; Laskarzewski PM; Quiter E; Held J
N Engl J Med; 1993 Apr; 328(17):1213-9. PubMed ID: 8464431
[TBL] [Abstract][Full Text] [Related]
12. A multicenter comparison of lovastatin and probucol for treatment of severe primary hypercholesterolemia. The Lovastatin Study Group IV.
Am J Cardiol; 1990 Sep; 66(8):22B-30B. PubMed ID: 2206033
[TBL] [Abstract][Full Text] [Related]
13. Reduction of LDL cholesterol in patients with primary hypercholesterolemia by SCH 48461: results of a multicenter dose-ranging study.
Dujovne CA; Bays H; Davidson MH; Knopp R; Hunninghake DB; Stein EA; Goldberg AC; Jones P; Lipka LJ; Cuffie-Jackson C
J Clin Pharmacol; 2001 Jan; 41(1):70-8. PubMed ID: 11144997
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia.
Lukacsko P; Walters EJ; Cullen EI; Niecestro R; Friedhoff LT
Curr Med Res Opin; 2004 Jan; 20(1):13-8. PubMed ID: 14741066
[TBL] [Abstract][Full Text] [Related]
15. A softgel dietary supplement containing esterified plant sterols and stanols improves the blood lipid profile of adults with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled replication study.
McKenney JM; Jenks BH; Shneyvas E; Brooks JR; Shenoy SF; Cook CM; Maki KC
J Acad Nutr Diet; 2014 Feb; 114(2):244-249. PubMed ID: 24287284
[TBL] [Abstract][Full Text] [Related]
16. Hypercholesterolemia in postmenopausal women. Metabolic defects and response to low-dose lovastatin.
Arca M; Vega GL; Grundy SM
JAMA; 1994 Feb; 271(6):453-9. PubMed ID: 8295321
[TBL] [Abstract][Full Text] [Related]
17. Comparison of gemfibrozil and lovastatin in patients with high low-density lipoprotein and low high-density lipoprotein cholesterol levels.
McKenney JM; Barnett MD; Wright JT; Proctor JP
Arch Intern Med; 1992 Sep; 152(9):1781-7. PubMed ID: 1520045
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind comparison of cerivastatin and lovastatin for treatment of primary hypercholesterolemia.
Yu WC; Chen CH; Tsao HM; Ding YA
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Jun; 65(6):260-7. PubMed ID: 12201566
[TBL] [Abstract][Full Text] [Related]
19. [The comparative treatment with lovastatin and bezafibrate of primary hypercholesterolemia. A randomized and double-blind trial].
Sánchez Domínguez J; Rodríguez Padial L; Navarro A; Barcina C; Fernández E; Rivera G; Cuesta L; Lázaro-Carrasco E
Rev Esp Cardiol; 1991 Apr; 44(4):251-7. PubMed ID: 2068368
[TBL] [Abstract][Full Text] [Related]
20. Design & rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
Downs JR; Beere PA; Whitney E; Clearfield M; Weis S; Rochen J; Stein EA; Shapiro DR; Langendorfer A; Gotto AM
Am J Cardiol; 1997 Aug; 80(3):287-93. PubMed ID: 9264420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
